Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Current Comment

Current Comment JAMA Revisited October 18, 1919 protection against exploitation, it has been deemed necessary in certain instances to protect the discoveries by patents. It is the purpose of the institute to permit any drugs which may prove of practical therapeutic value to be manufactured under license by suitable chemical firms and under conditions of production Patenting Therapeutic Agents which will insure the biological qualities of the drugs and their marketing at reasonable prices. Other than through the issuance In the past, therapeutic agents and apparatus have been con- trolled by patents and trademarks for profit. If there have been of license, the Rockefeller Institute does not participate in any exceptions, they have been rare. The Principles of Medical Eth- way in the commercial preparation or sale of the manufactured ics of the American Medical Association contain this state- chemicals; and it receives no royalties or other pecuniary ben- ment: “It is unprofessional to receive remuneration from pat- efits from the licenses it issues.” ents for surgical instruments or medicines.” This does not mean Here we have medicine at its best. The altruism of pure sci- that the patenting is wrong in itself; there are occasions when ence operating for the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Current Comment

JAMA , Volume 322 (15) – Oct 15, 2019
Download PDF
1 page

Current Comment

Abstract

JAMA Revisited October 18, 1919 protection against exploitation, it has been deemed necessary in certain instances to protect the discoveries by patents. It is the purpose of the institute to permit any drugs which may prove of practical therapeutic value to be manufactured under license by suitable chemical firms and under conditions of production Patenting Therapeutic Agents which will insure the biological qualities of the drugs and their marketing at reasonable prices. Other than through...
Loading next page...
 
/lp/american-medical-association/current-comment-gcdAe8e1D2

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2018.15561
Publisher site
See Article on Publisher Site

Abstract

JAMA Revisited October 18, 1919 protection against exploitation, it has been deemed necessary in certain instances to protect the discoveries by patents. It is the purpose of the institute to permit any drugs which may prove of practical therapeutic value to be manufactured under license by suitable chemical firms and under conditions of production Patenting Therapeutic Agents which will insure the biological qualities of the drugs and their marketing at reasonable prices. Other than through the issuance In the past, therapeutic agents and apparatus have been con- trolled by patents and trademarks for profit. If there have been of license, the Rockefeller Institute does not participate in any exceptions, they have been rare. The Principles of Medical Eth- way in the commercial preparation or sale of the manufactured ics of the American Medical Association contain this state- chemicals; and it receives no royalties or other pecuniary ben- ment: “It is unprofessional to receive remuneration from pat- efits from the licenses it issues.” ents for surgical instruments or medicines.” This does not mean Here we have medicine at its best. The altruism of pure sci- that the patenting is wrong in itself; there are occasions when ence operating for the

Journal

JAMA – American Medical Association

Published: Oct 15, 2019

There are no references for this article.